John Robertson Appointed to Advance Nanotech Board of Directors
Professor Robertson is currently a professor of electronics at Cambridge University. Previously he was a reader in solid state electronics, a university lecturer and research associate, all at Cambridge University. Prior to his work at Cambridge, Professor Robertson served as a visiting professor at the University of Illinois. He also served as a research officer at the Leatherhead and Swindon Central Electricity Generating Board in the U.K. for nearly 20 years.
“We will rely on him for his scientific expertise and knowledge as we continue our strong growth trajectory. We thank Professor Milne for his valuable contribution to Advance Nanotech, wish him well and look forward to continuing to work with him.”
Professor Robertson's research covers a wide range of interests in electronics materials including carbon nanotubes, diamond-like carbon, amorphous silicon, and ferroelectric oxides. He has published over 400 papers, is currently the most cited staff member in the Cambridge engineering department and is a recipient of the T.P. Hoar Award for best paper in Corrosion Science. Professor Robertson earned his bachelor's and master's degrees in natural sciences from Churchill College at Cambridge University and a doctorate in physics from the Cavendish Laboratories at Cambridge University.
"Professor Robertson will make an excellent addition to our Board," said Magnus Gittins, CEO of Advance Nanotech. "We will rely on him for his scientific expertise and knowledge as we continue our strong growth trajectory. We thank Professor Milne for his valuable contribution to Advance Nanotech, wish him well and look forward to continuing to work with him."
Professor Robertson joins Advance Nanotech board members Lee J. Cole, Magnus Gittins, Tony Goncalves, Joe Parkinson, Peter Rugg, and Virgil E. Wenger.
Advance Nanotech is currently funding 26 nanotechnologies in the electronics, biopharma, and materials industries. The firm provides services ranging from funding, to human capital and research equipment essential to ensuring that the most promising companies can accelerate the path to rapid commercialization. In this way, investor exposure to any particular technology is mitigated with Advance Nanotech retaining the option to increase investment in those technologies that successfully mature.
About Advance Nanotech, Inc.
Advance Nanotech is dedicated to the successful commercialization of disruptive nanotechnologies to produce nano-enabled products. Advance provides financing and support services including commercialization guidance, project and infrastructure management, leadership assets, and counsel on intellectual property, licensing and regulatory issues to ensure maximum market potential. Advance Nanotech's diversified portfolio of 26 nanotechnologies, of which the company holds a majority stake in 21, impacts a range of applications including, but not limited to, sensors, medical therapeutics and composites. Advance is forging partnerships with leading manufacturers and universities in Europe, Asia and North America to transform innovative nanotechnology concepts into practical solutions. For more information on Advance Nanotech, please visit www.advancenanotech.com.
This document contains forward-looking statements by Advance Nanotech regarding its expectations as to its business, and involves risks and uncertainties and may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Such statements are based on management's current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements.
Factors that may cause such a difference include, but are not limited to, problems and risks associated with developments in the nanotechnology industry in general and in Advance Nanotech's products under development in particular; the potential failure of Advance Nanotech's products under development to prove safe and effective in application; uncertainties inherent in the early stage of Advance Nanotech's products under development; failure to successfully implement or complete research programmes; failure to receive marketing clearance from regulatory agencies for our products under development; acquisitions, divestitures, mergers, licenses or strategic initiatives that change Advance Nanotech's business, structure or projections; the development of competing products; uncertainties related to Advance Nanotech's dependence on third parties and partners; and those risks described Advance Nanotech 's filings with the SEC. Advance Nanotech disclaims any obligation to update these forward-looking statements.
Further information about these and other relevant risks and uncertainties may be found in the Advance Nanotech's findings with the Securities and Exchange Commission, all of which are available from the Commission as well as other sources.